NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.
Maven Income and Growth VCT PLC (the Company)
Offer for Subscription
21 March 2024
On 13 October 2023, alongside the other Maven VCTs, the Company announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to an offer for subscription of new Ordinary Shares of 10p each (the "Offer").
The Board of the Company is pleased to advise that, with valid subscriptions received to date under the Offer now approaching its initial fundraising target of £5 million, and in view of continued interest from potential investors, the Directors have resolved to make use of the over-allotment facility, as provided for under the terms and conditions of the Offer to the extent required to meet any additional demand.
The deadline for receipt of applications for the Offer is 9.00 am on 5 April 2024 in relation to the tax year 2023/24 and 5.00 pm on 26 April 2024 in relation to the tax year 2024/25. The Offer will close on 1 May 2024 unless it is fully subscribed by an earlier date or extended by the Board to no later than 11 October 2024.
Downloadable versions of the Prospectus documents are available at: mavencp.com/vctoffer.
Any enquiries in respect of the Offer, or requests for copies of the Prospectus documents (available free of charge), should be directed to:
Maven Capital Partners UK LLP
Kintyre House
205 West George Street
Glasgow
G2 2LW
Telephone: 0141 306 7400
E-mail: enquiries@mavencp.com
Maven Capital Partners UK LLP
Secretary
The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.
Notes
This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
